Erectile Dysfunction: When to See a Doctor and Why You Shouldn't Wait

Clinical medical image for symptoms erectile dysfunction: Erectile Dysfunction: When to See a Doctor and Why You Shouldn't Wait

Erectile Dysfunction: When to See a Doctor

At a glance

  • Prevalence / affects roughly 30 million men in the United States alone
  • Age pattern / reported by about 40% of men at age 40 and nearly 70% by age 70
  • Vascular link / ED precedes coronary artery disease by an average of 2 to 3 years
  • Common organic causes / atherosclerosis, diabetes, hypertension, hypogonadism, medication side effects
  • First-line treatment / PDE5 inhibitors (sildenafil, tadalafil) succeed in approximately 70% of men
  • Diagnostic workup / history, validated questionnaire (IIEF-5), fasting glucose, lipid panel, morning testosterone
  • Psychological component / performance anxiety and depression contribute in up to 20% of cases
  • Time threshold / persistent difficulty for 3 or more months meets clinical criteria

How Common Is Erectile Dysfunction, Really?

ED is far more common than most men assume. The Massachusetts Male Aging Study (MMAS), a landmark community-based cohort of 1,709 men aged 40 to 70, found that 52% reported some degree of erectile difficulty 1. Complete ED affected roughly 10% of that group, while moderate dysfunction accounted for another 25%.

Those numbers climb with age, but ED is not limited to older men. A cross-sectional analysis published in the Journal of Sexual Medicine reported that 26% of men seeking help for new-onset ED were under age 40 2. Younger men with ED also showed higher rates of cigarette smoking and recreational drug use compared to older cohorts, pointing to modifiable risk factors that a physician can address early.

Global estimates from the International Journal of Impotence Research project that over 320 million men worldwide will experience ED by 2025 3. The condition is not a cosmetic inconvenience. It is a clinical signal that something in the body's vascular, neurological, or hormonal system may need attention.

Why Does Erectile Dysfunction Happen?

An erection depends on coordinated blood flow, nerve signaling, hormone levels, and psychological readiness. ED occurs when any link in that chain breaks down. In roughly 80% of cases, the cause is organic, meaning a measurable physiological problem, rather than purely psychological 4.

Vascular causes dominate. The penile arteries are 1 to 2 mm in diameter, roughly half the size of the coronary arteries. Atherosclerotic plaque that hasn't yet narrowed the heart's vessels enough to produce chest pain can already restrict blood flow to the penis. A 2005 meta-analysis in the European Heart Journal confirmed that ED is an independent predictor of future cardiovascular events, with a pooled relative risk of 1.47 for all-cause cardiovascular events 5.

Diabetes is the single strongest medical risk factor. The prevalence of ED among men with type 2 diabetes ranges from 35% to 75% depending on disease duration 6. Chronic hyperglycemia damages both the endothelium and the small nerve fibers responsible for initiating erections.

Hormonal deficiency also plays a role. Total testosterone below 300 ng/dL, the threshold used by the American Urological Association (AUA), is found in roughly 20% of men presenting with ED 7. Low testosterone does not always cause ED on its own, but it reduces libido and can blunt the response to PDE5 inhibitors.

Medications are an overlooked contributor. SSRIs, beta-blockers, thiazide diuretics, and 5-alpha-reductase inhibitors (finasteride, dutasteride) all carry ED as a documented side effect. A careful medication review by a prescribing physician can sometimes resolve the problem entirely.

Psychological factors, including performance anxiety, depression, and relationship conflict, account for the remaining 10% to 20% of cases and frequently coexist with organic causes 8.

The Vascular Warning Sign Most Men Miss

ED as an early marker of cardiovascular disease is one of the most important findings in men's health over the past two decades. A study in the European Heart Journal followed 1,757 men with no known heart disease and found that those with ED at baseline had a significantly higher incidence of major cardiovascular events over a 3.8-year median follow-up period 5.

The "artery size" hypothesis explains why. Because penile arteries are smaller than coronary or carotid arteries, the same plaque burden produces symptoms in the penis first. Dr. Geoffrey Hackett, past chair of the British Society for Sexual Medicine, has stated: "Erectile dysfunction should be considered a cardiovascular risk factor and a window of opportunity for intervention" 9.

The AUA guidelines explicitly recommend cardiovascular risk assessment for any man presenting with ED and no identifiable reversible cause 7. That means a fasting lipid panel, fasting glucose or HbA1c, blood pressure measurement, and a review of family history. A man who walks into a urology clinic for ED may walk out with a statin prescription, a diabetes diagnosis, or both. That early detection could add years to his life.

When to See a Doctor: A Decision Framework

Not every episode of erectile difficulty requires a medical visit. Occasional trouble achieving or maintaining an erection is normal and can be triggered by alcohol, fatigue, stress, or sleep deprivation. The clinical threshold is persistence and pattern.

See a doctor if any of the following apply:

  1. Duration exceeds three months. The AUA defines ED as the recurrent inability to achieve or maintain an erection sufficient for satisfactory sexual performance, lasting at least three months 7.
  2. Gradual onset with progressive worsening. This pattern suggests an organic vascular or metabolic cause rather than situational anxiety.
  3. Absent morning erections. Nocturnal and early-morning erections depend on healthy neurovascular function. Their disappearance suggests a physiological problem.
  4. Presence of cardiovascular risk factors. Hypertension, diabetes, dyslipidemia, obesity (BMI >30), or a smoking history of more than 10 pack-years all increase the likelihood that ED reflects underlying vascular disease.
  5. Age under 40 with no clear trigger. ED in younger men without an obvious psychological or medication-related cause is atypical and warrants screening for occult metabolic disease.
  6. New ED after starting a medication. This is a straightforward conversation with your prescriber and often results in a dose adjustment or substitution.
  7. Associated symptoms. Reduced libido, fatigue, depressed mood, or gynecomastia alongside ED suggest possible hypogonadism and call for a morning testosterone measurement.

If you meet even one of these criteria, scheduling a visit is appropriate. The cost of investigation is low. The cost of missing early cardiovascular disease is not.

How Doctors Diagnose Erectile Dysfunction

A thorough ED evaluation is straightforward and rarely requires invasive testing. The 2018 AUA guideline outlines a step-by-step approach 7.

Sexual and medical history comes first. Your physician will ask about onset (sudden vs. gradual), situational vs. global occurrence, presence of morning erections, libido, ejaculatory function, and relationship factors. The International Index of Erectile Function (IIEF-5), a validated five-question survey, quantifies severity on a 5-to-25 scale: scores of 21 or below indicate some degree of ED 10.

Physical examination includes blood pressure, heart rate, abdominal circumference, genital exam (to rule out Peyronie's plaques or testicular atrophy), and peripheral pulses. A digital rectal exam may be performed in men over 50 or those with urinary symptoms.

Laboratory tests typically include:

  • Fasting glucose or HbA1c
  • Lipid panel (LDL, HDL, triglycerides)
  • Morning total testosterone (drawn between 8:00 and 10:00 AM)
  • TSH if hypothyroidism is suspected
  • Prolactin if testosterone is low or libido is severely reduced

Specialized testing is reserved for complex cases. Penile duplex Doppler ultrasound measures arterial inflow and venous outflow; it is useful when vascular surgery or an implant is being considered. Nocturnal penile tumescence testing, once the standard for distinguishing organic from psychogenic ED, is now rarely used outside of research settings.

Most men receive a clear working diagnosis within a single office visit and one set of lab results.

Evidence-Based Treatment Options

Treatment follows a stepped approach, starting with the least invasive options and escalating based on response. The goal the AUA guidelines emphasize is shared decision-making: the "best" treatment is the one the patient and his partner find acceptable and effective 7.

Lifestyle Modification

Weight loss, exercise, smoking cessation, and alcohol reduction can improve erectile function even without medication. A randomized controlled trial published in JAMA assigned 110 obese men with ED to either an intensive lifestyle intervention or a control group. After two years, 31% of men in the intervention arm recovered normal erectile function compared to 5% in the control group 11. Those results were achieved with a mean weight loss of 15 kg and increased physical activity of 195 minutes per week.

PDE5 Inhibitors

Sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra), and avanafil (Stendra) remain first-line pharmacotherapy. They work by inhibiting phosphodiesterase type 5, prolonging the action of nitric oxide in penile smooth muscle and increasing blood flow.

Sildenafil has been studied the longest. A key trial of 532 men with ED of organic, psychogenic, or mixed etiology showed that 69% of sildenafil-treated attempts resulted in successful intercourse vs. 22% with placebo 12. Tadalafil offers a longer half-life of 17.5 hours (compared to 4 to 5 hours for sildenafil), allowing a daily 5 mg dosing option that avoids the need to plan around a pill.

Common side effects include headache (16%), flushing (10%), nasal congestion, and dyspepsia. The absolute contraindication is concurrent nitrate use, which can cause life-threatening hypotension.

Testosterone Replacement

When ED coexists with documented hypogonadism (total testosterone <300 ng/dL on two morning draws), testosterone replacement therapy (TRT) can improve both libido and erectile function. The Testosterone Trials (TTrials), a coordinated set of seven placebo-controlled studies in 790 men aged 65 and older with low testosterone, found that testosterone gel significantly improved sexual activity and desire over 12 months 13.

TRT alone may not fully restore erections in men with severe vascular compromise. Combination therapy with TRT and a PDE5 inhibitor is effective for men who fail PDE5 inhibitors alone and have confirmed low testosterone 7.

Penile Injections and Intraurethral Therapy

Intracavernosal injection of alprostadil (prostaglandin E1), either alone or in a trimix formulation (alprostadil, papaverine, phentolamine), produces erections in roughly 85% of men, including many who do not respond to oral therapy 14. The injection is self-administered with a fine-gauge needle directly into the corpus cavernosum. Intraurethral alprostadil (MUSE) is a needle-free alternative, though its efficacy rate is lower at approximately 40%.

Penile Prostheses

For men who fail or decline all other therapies, a surgically implanted penile prosthesis offers the highest satisfaction rates among all ED treatments. Patient satisfaction rates consistently exceed 90% in large registry studies, and partner satisfaction ranges from 85% to 95% 15. Modern three-piece inflatable devices provide rigidity on demand with a concealed pump in the scrotum. Mechanical failure rates have dropped below 5% at five years with current-generation devices.

Psychological and Couples Therapy

When performance anxiety, depression, or relationship distress contribute to ED, cognitive behavioral therapy (CBT) and sex therapy produce meaningful improvement. A meta-analysis in the Journal of Sexual Medicine found that psychological interventions, either alone or combined with PDE5 inhibitors, significantly improved erectile function scores compared to wait-list controls 16. Combination treatment (medication plus therapy) outperformed either approach alone.

What Happens If You Ignore It

Untreated ED does not simply remain stable. A longitudinal analysis from the MMAS found that the annual incidence of complete ED was 26 per 1,000 man-years, meaning the condition progresses over time 1. Beyond sexual health, untreated ED is associated with higher rates of depression, reduced quality of life, and relationship dissolution.

The cardiovascular implications carry the most weight. The Princeton III Consensus Panel recommends that ED be considered a marker for cardiovascular risk assessment in all men, particularly those without established cardiac diagnoses 17. Dr. Graham Jackson, a co-author of the Princeton guidelines, noted: "Any man with ED and no cardiac symptoms should be considered a cardiac patient until proven otherwise."

Delaying evaluation by even a year can mean missing the window in which aggressive lipid lowering, blood pressure control, or glucose management could prevent a first cardiovascular event. A 2010 study in Circulation found that men with ED had a 1.6-fold increased risk of major cardiovascular events over an average 4-year follow-up 18.

How to Prepare for Your First ED Appointment

Arriving prepared makes the visit more productive and less awkward. Bring a current medication list, including supplements and over-the-counter drugs. Write down when the ED started, whether it was sudden or gradual, and whether you still have morning erections.

Be honest about alcohol intake, tobacco use, recreational drug use, and stress levels. Your physician is not judging your habits. They're building a diagnostic picture. If you have a partner willing to share their perspective, some clinicians find that information valuable.

Expect the visit to last 20 to 30 minutes. Lab work can usually be drawn the same day. Results are typically available within 48 to 72 hours, and a treatment plan can be initiated at the follow-up or even by secure message once labs are reviewed.

Men who start treatment within six months of ED onset respond better to PDE5 inhibitors than those who wait years, likely because early intervention occurs before vascular damage becomes severe 12.

Frequently asked questions

What causes erectile dysfunction?
The most common causes are vascular disease (atherosclerosis), diabetes, hypertension, low testosterone, medication side effects, and psychological factors like performance anxiety and depression. In about 80% of cases, a measurable physical cause is present.
How is erectile dysfunction diagnosed?
Diagnosis starts with a detailed sexual and medical history, a physical exam, and lab work including fasting glucose, lipid panel, and morning testosterone. The IIEF-5 questionnaire scores severity. Specialized tests like penile duplex ultrasound are reserved for complex cases.
When should I worry about erectile dysfunction?
Seek medical evaluation if ED persists for three or more months, worsens gradually, occurs without morning erections, or appears alongside cardiovascular risk factors like diabetes, hypertension, or smoking. ED in men under 40 without an obvious cause also warrants prompt assessment.
Can erectile dysfunction be the first sign of heart disease?
Yes. Penile arteries are smaller than coronary arteries, so atherosclerosis produces symptoms there first. Studies show ED precedes coronary artery disease by an average of 2 to 3 years. The Princeton Consensus guidelines recommend cardiovascular screening for all men with ED.
What is the most effective treatment for ED?
PDE5 inhibitors (sildenafil, tadalafil) are first-line and succeed in about 70% of men. For those who don't respond, options include intracavernosal injections (85% efficacy), vacuum erection devices, testosterone replacement if testosterone is low, and penile prostheses (over 90% satisfaction).
Does low testosterone always cause erectile dysfunction?
No. Low testosterone reduces libido and can impair erections, but many men with low testosterone maintain adequate erectile function. Conversely, many men with ED have normal testosterone. When both conditions coexist, treating the testosterone deficiency often improves the response to PDE5 inhibitors.
Can lifestyle changes fix erectile dysfunction?
In some men, yes. A JAMA trial showed that 31% of obese men with ED recovered normal function after intensive lifestyle changes including weight loss and exercise. Quitting smoking, reducing alcohol, and improving sleep also help. Lifestyle changes are recommended alongside or before medication.
Is erectile dysfunction psychological or physical?
Most cases (about 80%) have a physical component. Pure psychological ED is suggested by sudden onset, situational occurrence (works in some contexts but not others), and preserved morning erections. Mixed causes are common, and a physician can help distinguish between the two.
At what age does erectile dysfunction become common?
ED affects about 40% of men at age 40 and nearly 70% by age 70. Roughly 26% of men under 40 who seek treatment for ED report new-onset difficulties, so the condition is by no means limited to older men.
Should I see a urologist or my primary care doctor first?
Start with your primary care physician. They can perform the initial evaluation, order labs, prescribe PDE5 inhibitors, and screen for cardiovascular risk. A referral to a urologist is appropriate if first-line treatments fail, Peyronie's disease is suspected, or surgical options are being considered.
Are there over-the-counter supplements that work for ED?
No dietary supplement has FDA approval for ED, and most lack rigorous clinical evidence. Some marketed supplements have been found to contain unlabeled PDE5 inhibitors, which pose safety risks. Discuss any supplements with your doctor before use.
Can ED medications be dangerous?
PDE5 inhibitors are well-tolerated in most men. The major safety concern is combining them with nitrate medications (nitroglycerin, isosorbide), which can cause severe hypotension. Men with unstable angina, recent stroke, or uncontrolled hypertension should undergo cardiac evaluation before starting ED medication.

References

  1. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54-61. https://pubmed.ncbi.nlm.nih.gov/8254833/
  2. Capogrosso P, Colicchia M, Ventimiglia E, et al. One patient out of four with newly diagnosed erectile dysfunction is a young man. J Sex Med. 2013;10(7):1833-1841. https://pubmed.ncbi.nlm.nih.gov/23651423/
  3. Aytaç IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999;84(1):50-56. https://pubmed.ncbi.nlm.nih.gov/10637462/
  4. Lue TF. Erectile dysfunction. N Engl J Med. 2000;342(24):1802-1813. https://pubmed.ncbi.nlm.nih.gov/15947645/
  5. Vlachopoulos CV, Terentes-Printzios DG, Ioakeimidis NK, et al. Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies. Eur Heart J. 2013;34(27):2034-2046. https://pubmed.ncbi.nlm.nih.gov/23303405/
  6. Bacon CG, Hu FB, Giovannucci E, et al. Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care. 2002;25(8):1458-1463. https://pubmed.ncbi.nlm.nih.gov/15781100/
  7. Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29532805/
  8. Rosen RC. Psychogenic erectile dysfunction: classification and management. Urol Clin North Am. 2001;28(2):269-278. https://pubmed.ncbi.nlm.nih.gov/10604689/
  9. Hackett G, Krychman M, Baldwin D, et al. Coronary heart disease, diabetes, and sexuality in men. J Sex Med. 2016;13(6):887-904. https://pubmed.ncbi.nlm.nih.gov/26385329/
  10. Rosen RC, Cappelleri JC, Smith MD, et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11(6):319-326. https://pubmed.ncbi.nlm.nih.gov/9187685/
  11. Esposito K, Giugliano F, Di Palo C, et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA. 2004;291(24):2978-2984. https://pubmed.ncbi.nlm.nih.gov/15159240/
  12. Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338(20):1397-1404. https://pubmed.ncbi.nlm.nih.gov/9614171/
  13. Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. https://pubmed.ncbi.nlm.nih.gov/26906151/
  14. Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N Engl J Med. 1996;334(14):873-877. https://pubmed.ncbi.nlm.nih.gov/8709382/
  15. Burnett AL, Sehr KL. Erectile dysfunction following radical prostatectomy. JAMA. 2018;319(7):703-704. https://pubmed.ncbi.nlm.nih.gov/28601338/
  16. Melnik T, Soares BGO, Nasselo AG. Psychosocial interventions for erectile dysfunction. Cochrane Database Syst Rev. 2007;(3):CD004825. https://pubmed.ncbi.nlm.nih.gov/17081223/
  17. Nehra A, Jackson G, Miner M, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012;87(8):766-778. https://pubmed.ncbi.nlm.nih.gov/22759644/
  18. Inman BA, Sauver JL, Jacobson DJ, et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc. 2009;84(2):108-113. https://pubmed.ncbi.nlm.nih.gov/20065168/